Teva Pharmaceutical Industries Ltd (TEVA) is up Monday morning, with the stock adding 1.42% in pre-market trading to 8.59. TEVA's short-term technical score of 51 indicates that the stock has traded more bullishly over the last month than 51% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 141 out of 146 industries, Teva Pharmaceutical Industries Ltd ranks higher than 71% of stocks. Teva Pharmaceutical Industries Ltd has fallen 7.13% over the past month, closing at $9.13 on April 25. During this period of time, the stock fell as low as $7.38 and as high as $9.16. TEVA has an average analyst recommendation of Buy. The company has an average price target of $10.13.
TEVA has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on TEVA!